Farallon Capital Partners, L.P.

13F Holdings History for Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX)

Symbol: TNGX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 10.8M shares
Security Ownership: 9.7%

Dapice Joshua J. ownership in Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX)

2025-11-12 - Dapice Joshua J. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.8M shares of Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX). This represents 9.7% percent ownership of the company. In their previous filing dated 2025-08-13, Farallon Capital Partners, L.P. had reported owning 9.16M shares, indicating an increase of 17.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Dapice Joshua J.	9.7%	+16.3%	$90.4M	10.8M	+1,600,000	+17.5%	$8.40	13G/A	9/30/2025	12 Nov 2025 12:17:55
Dapice Joshua J.	8.4%	+25.7%	$63.2M	9.16M	+1,975,000	+27.5%	$6.90	13G/A	6/30/2025	13 Aug 2025 17:00:42
Dapice Joshua J.	6.6%		$8.19M	7.18M			$1.14	13G	6/6/2025	13 Jun 2025 17:25:29